Please Wait
Applying Filters...
menu
    • menu
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Inke S.A: APIs manufacturing plant.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Psilocybine

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    DIGITAL CONTENT

    MARKET PLACE

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Avextra Supports EU-Funded Psilocybin Study, EMA Approval Granted
    Avextra Supports EU-Funded Psilocybin Study, EMA Approval Granted

    12 Dec 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/12/12/2996054/0/en/Avextra-Supports-1st-Fully-EU-Funded-Psilocybin-Therapy-Study-Now-Approved-by-EMA.html

    GLOBENEWSWIRE
    12 Dec 2024
    Share Share
    Revive Therapeutics Publishes Psilocybin Stroke Approach
    Revive Therapeutics Publishes Psilocybin Stroke Approach

    12 Nov 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/11/12/2979017/0/en/Revive-Therapeutics-Announces-Publication-Demonstrating-Novel-Therapeutic-Approach-of-Psilocybin-in-Stroke.html

    GLOBENEWSWIRE
    12 Nov 2024
    Share Share
    Dr. Michael Bogenschutz Wins $15M NIDA Grant for Psilocybin Study
    Dr. Michael Bogenschutz Wins $15M NIDA Grant for Psilocybin Study

    31 Oct 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/bmore-collaborator-dr-michael-bogenschutz-awarded-15-million-nida-grant-for-landmark-psilocybin-study-in-opioid-use-disorder-302287350.html

    PR NEWSWIRE
    31 Oct 2024
    Share Share
    Psyence walks away from acquisition of fellow psilocybin biotech
    Psyence walks away from acquisition of fellow psilocybin biotech

    07 Oct 2024

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/psyence-walks-away-acquisition-fellow-psilocybin-biotech-clairvoyant

    FIERCE BIOTECH
    07 Oct 2024
    Share Share
    Psyence Biomed Licenses PsyLabs' Nature-Derived Psilocybin
    Psyence Biomed Licenses PsyLabs' Nature-Derived Psilocybin

    04 Sep 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/09/04/2940401/0/en/Psyence-Biomed-Announces-Worldwide-Exclusive-Licensing-Agreement-with-PsyLabs-to-Supply-Nature-Derived-Psilocybin-to-be-Evaluated-as-a-Potential-Treatment-for-Alcohol-Use-Disorder-.html

    GLOBENEWSWIRE
    04 Sep 2024
    Share Share
    MindTrek's Psilocybin Therapy Shows Positive Results For Couples On The Brink
    MindTrek's Psilocybin Therapy Shows Positive Results For Couples On The Brink

    16 Aug 2024

    // ACCESSWIRE

    https://www.accesswire.com/viewarticle.aspx?id=902603&lang=en

    ACCESSWIRE
    16 Aug 2024
    Share Share